Blend Labs (BLND) vs Health Catalyst (HCAT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Health Catalyst (HCAT) has outperformed Blend Labs (BLND) over the past year, losing 44.5% versus a loss of 72.6%. Over five years, BLND leads with a -92.4% price change compared with -97.0% for HCAT. Blend Labs is the larger company by market cap ($196.5 million vs $99.8 million), about 2.0 times the size.
Blend Labs converts more of its revenue into profit, with a net margin of -5.5% versus -57.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLND | HCAT |
|---|---|---|
| Share price | $0.8247 | $1.31 |
| Market cap | $196.50M | $99.76M |
| 1-day change | -6.73% | +1.55% |
| YTD return | -72.87% | -45.19% |
| 1-year return | -72.60% | -44.49% |
| 5-year return | -92.43% | -97.00% |
| Forward P/E | 14.34 | — |
| EPS (TTM) | $-0.13 | $-2.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $123.58M | $311.14M |
| Revenue growth (YoY) | +6.76% | +1.48% |
| Net income (latest FY) | $-6.80M | $-177.97M |
| Gross margin | 73.77% | 48.75% |
| Operating margin | -17.59% | -51.70% |
| Net margin | -5.50% | -57.20% |
| 52-week high | $3.44 | $3.03 |
| 52-week low | $0.782 | $0.955 |
| Distance from 52-week high | -75.99% | -56.69% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +165.55% | +35.11% |
| Average volume | 1.65M | 414.24K |
| Shares outstanding | 235.01M | 76.16M |
| Employees | 419 | 1,200 |
| Sector | Technology | Technology |
| Industry | Computer Software: Programming Data Processing | Computer Software: Programming Data Processing |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HCAT has outperformed BLND by 28.1 percentage points over the past year.
- Blend Labs is more profitable, keeping -5.5 cents of every revenue dollar as net income versus -57.2 cents for Health Catalyst.
- Blend Labs grew revenue faster in its latest fiscal year (+6.76% vs +1.48%).
About Blend Labs
BLND stock →Blend Labs, Inc. provides a cloud-based software platform for financial services firms in the United States, India, and Mexico.
Technology · Computer Software: Programming Data Processing · 419 employees
About Health Catalyst
HCAT stock →Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States.
Technology · Computer Software: Programming Data Processing · 1,200 employees
BLND vs HCAT FAQ
Which is bigger, Blend Labs or Health Catalyst?
Blend Labs (BLND) is larger, with a market capitalization of $196.50M compared with $99.76M for Health Catalyst (HCAT).
Which stock has performed better over the past year, BLND or HCAT?
HCAT returned -44.49% over the past 12 months, compared with -72.60% for BLND (price return, excluding dividends). Past performance does not predict future results.
Are Blend Labs and Health Catalyst in the same industry?
Yes. Both are classified in the Computer Software: Programming Data Processing industry within the Technology sector.